Patricia Ann Duffy

Array ( [id] => 4681842 [patent_doc_number] => 20080248068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Use of Flagellin as an Adjuvant for Vaccine' [patent_app_type] => utility [patent_app_number] => 11/579324 [patent_app_country] => US [patent_app_date] => 2005-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12222 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20080248068.pdf [firstpage_image] =>[orig_patent_app_number] => 11579324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7135968 [patent_doc_number] => 20050180987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Method of separating protective components of bordetella pertussis' [patent_app_type] => utility [patent_app_number] => 11/105540 [patent_app_country] => US [patent_app_date] => 2005-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9047 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20050180987.pdf [firstpage_image] =>[orig_patent_app_number] => 11105540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9286414 [patent_doc_number] => 08642743 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-04 [patent_title] => 'Method for reducing the immune response to a biologically active protein' [patent_app_type] => utility [patent_app_number] => 11/547888 [patent_app_country] => US [patent_app_date] => 2005-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 27 [patent_no_of_words] => 20529 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11547888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5637507 [patent_doc_number] => 20060068480 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'Polypeptides and polypeptide analogues' [patent_app_type] => utility [patent_app_number] => 11/084860 [patent_app_country] => US [patent_app_date] => 2005-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 15460 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20060068480.pdf [firstpage_image] =>[orig_patent_app_number] => 11084860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4624087 [patent_doc_number] => 08003382 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-23 [patent_title] => 'Nucleic acid molecules encoding a house dust mite allergen Der f VII, and antigenic peptides thereof' [patent_app_type] => utility [patent_app_number] => 11/084057 [patent_app_country] => US [patent_app_date] => 2005-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16241 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/003/08003382.pdf [firstpage_image] =>[orig_patent_app_number] => 11084057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7004611 [patent_doc_number] => 20050169924 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'BAFF, inhibitors thereof and their use in the modulation of B-cell response' [patent_app_type] => utility [patent_app_number] => 11/080973 [patent_app_country] => US [patent_app_date] => 2005-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 15665 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20050169924.pdf [firstpage_image] =>[orig_patent_app_number] => 11080973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 173546 [patent_doc_number] => 07658925 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-09 [patent_title] => 'Human anthrax toxin neutralizing monoclonal antibodies and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/072102 [patent_app_country] => US [patent_app_date] => 2005-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 15561 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/658/07658925.pdf [firstpage_image] =>[orig_patent_app_number] => 11072102 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5720372 [patent_doc_number] => 20060073146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => 'Uses of agonists and antagonists to modulate activity of TNF-related molecules' [patent_app_type] => utility [patent_app_number] => 11/069473 [patent_app_country] => US [patent_app_date] => 2005-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 33929 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20060073146.pdf [firstpage_image] =>[orig_patent_app_number] => 11069473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7069028 [patent_doc_number] => 20050244411 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders' [patent_app_type] => utility [patent_app_number] => 11/065669 [patent_app_country] => US [patent_app_date] => 2005-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 20979 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20050244411.pdf [firstpage_image] =>[orig_patent_app_number] => 11065669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4669380 [patent_doc_number] => 20080044440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'Vaccine Formulated For Administration To Mucosa Of The Lungs' [patent_app_type] => utility [patent_app_number] => 10/589710 [patent_app_country] => US [patent_app_date] => 2005-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8890 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20080044440.pdf [firstpage_image] =>[orig_patent_app_number] => 10589710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7196192 [patent_doc_number] => 20050164279 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Secreted and transmembrane polypetides and nucleic acids encoding the same' [patent_app_type] => utility [patent_app_number] => 11/060240 [patent_app_country] => US [patent_app_date] => 2005-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 33927 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20050164279.pdf [firstpage_image] =>[orig_patent_app_number] => 11060240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6996697 [patent_doc_number] => 20050136475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-23 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => utility [patent_app_number] => 11/060652 [patent_app_country] => US [patent_app_date] => 2005-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 34035 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20050136475.pdf [firstpage_image] =>[orig_patent_app_number] => 11060652 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8737822 [patent_doc_number] => 08409590 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-02 [patent_title] => 'Anthrax antigens and methods of use' [patent_app_type] => utility [patent_app_number] => 10/589290 [patent_app_country] => US [patent_app_date] => 2005-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 19 [patent_no_of_words] => 23335 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10589290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4982793 [patent_doc_number] => 20070087351 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-19 [patent_title] => 'Orotate transporter encoding maker genes' [patent_app_type] => utility [patent_app_number] => 10/586932 [patent_app_country] => US [patent_app_date] => 2005-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 16578 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20070087351.pdf [firstpage_image] =>[orig_patent_app_number] => 10586932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4458917 [patent_doc_number] => 07879328 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-01 [patent_title] => 'Antibodies that immunospecifically bind to B lymphocyte stimulator' [patent_app_type] => utility [patent_app_number] => 11/054515 [patent_app_country] => US [patent_app_date] => 2005-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 196717 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/879/07879328.pdf [firstpage_image] =>[orig_patent_app_number] => 11054515 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 582440 [patent_doc_number] => 07442373 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-28 [patent_title] => 'Antibodies against protective antigen and methods of use for passive immunization and treatment of anthrax' [patent_app_type] => utility [patent_app_number] => 11/041318 [patent_app_country] => US [patent_app_date] => 2005-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 31 [patent_no_of_words] => 20843 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/442/07442373.pdf [firstpage_image] =>[orig_patent_app_number] => 11041318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6930796 [patent_doc_number] => 20050281830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Detection, prevention, and treatment systems for anthrax' [patent_app_type] => utility [patent_app_number] => 11/041471 [patent_app_country] => US [patent_app_date] => 2005-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 20848 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20050281830.pdf [firstpage_image] =>[orig_patent_app_number] => 11041471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4943717 [patent_doc_number] => 20080081042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-03 [patent_title] => 'Passive Immunization and methods of treament for anthrax using antibodies' [patent_app_type] => utility [patent_app_number] => 11/041763 [patent_app_country] => US [patent_app_date] => 2005-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 20830 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20080081042.pdf [firstpage_image] =>[orig_patent_app_number] => 11041763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5834249 [patent_doc_number] => 20060246079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Neutralizing human antibodies to anthrax toxin' [patent_app_type] => utility [patent_app_number] => 11/040580 [patent_app_country] => US [patent_app_date] => 2005-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 20822 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20060246079.pdf [firstpage_image] =>[orig_patent_app_number] => 11040580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5415895 [patent_doc_number] => 20090041782 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'Novel serotype streptococcus mutans and utilization of the same' [patent_app_type] => utility [patent_app_number] => 10/584990 [patent_app_country] => US [patent_app_date] => 2004-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 25669 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20090041782.pdf [firstpage_image] =>[orig_patent_app_number] => 10584990 [rel_patent_id] =>[rel_patent_doc_number] =>)